Dr. Ken Cunningham
Chief Executive Officer
Dr Ken Cunningham joined the Company as Chief Operating Officer in April 2006, was appointed to the Board in May 2006 and became Chief Executive Officer on 1 September 2008. Previously, he was CEO of Arakis Ltd, Vice-President European Affairs at Alza Corporation and Vice-President Clinical Development at Sequus Inc. Prior to this he held a variety of clinical development and commercial strategy roles at GlaxoWellcome plc and Warner-Lambert earlier in his career. Dr Cunningham is a Non-Executive Director of Xention Ltd. He holds a medical degree from St Mary's Medical School, London University.
back to Management and Directors
Copyright 2008, SkyePharma. All Rights Reserved.
SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 105 Piccadilly, London, W1J 7NJ, United Kingdom
